X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs LUPIN LTD - Comparison Results

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS LUPIN LTD DR. DATSONS LABS/
LUPIN LTD
 
P/E (TTM) x -10.9 17.0 - View Chart
P/BV x 0.2 4.0 4.1% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 DR. DATSONS LABS   LUPIN LTD
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
LUPIN LTD
Mar-16
DR. DATSONS LABS/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs1262,127 5.9%   
Low Rs311,294 2.4%   
Sales per share (Unadj.) Rs133.0304.1 43.7%  
Earnings per share (Unadj.) Rs0.250.4 0.3%  
Cash flow per share (Unadj.) Rs6.660.7 10.9%  
Dividends per share (Unadj.) Rs07.50 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs128.8243.8 52.8%  
Shares outstanding (eoy) m31.66450.58 7.0%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.65.6 10.5%   
Avg P/E ratio x516.133.9 1,520.6%  
P/CF ratio (eoy) x11.828.2 42.0%  
Price / Book Value ratio x0.67.0 8.7%  
Dividend payout %014.9 0.0%   
Avg Mkt Cap Rs m2,477770,740 0.3%   
No. of employees `000NA16.4 0.0%   
Total wages/salary Rs m5621,077 0.3%   
Avg. sales/employee Rs ThNM8,379.6-  
Avg. wages/employee Rs ThNM1,289.0-  
Avg. net profit/employee Rs ThNM1,388.7-  
INCOME DATA
Net Sales Rs m4,211137,016 3.1%  
Other income Rs m791,877 4.2%   
Total revenues Rs m4,289138,893 3.1%   
Gross profit Rs m56937,535 1.5%  
Depreciation Rs m2044,635 4.4%   
Interest Rs m430446 96.4%   
Profit before tax Rs m1334,330 0.0%   
Minority Interest Rs m0-88 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m611,536 0.1%   
Profit after tax Rs m522,707 0.0%  
Gross profit margin %13.527.4 49.3%  
Effective tax rate %48.033.6 142.9%   
Net profit margin %0.116.6 0.7%  
BALANCE SHEET DATA
Current assets Rs m6,85297,790 7.0%   
Current liabilities Rs m6,71153,872 12.5%   
Net working cap to sales %3.332.1 10.4%  
Current ratio x1.01.8 56.2%  
Inventory Days Days16185 189.9%  
Debtors Days Days318121 262.8%  
Net fixed assets Rs m3,67386,379 4.3%   
Share capital Rs m317901 35.1%   
"Free" reserves Rs m3,761105,735 3.6%   
Net worth Rs m4,078109,844 3.7%   
Long term debt Rs m1,67153,739 3.1%   
Total assets Rs m12,633224,378 5.6%  
Interest coverage x1.077.9 1.3%   
Debt to equity ratio x0.40.5 83.8%  
Sales to assets ratio x0.30.6 54.6%   
Return on assets %3.410.3 33.4%  
Return on equity %0.120.7 0.6%  
Return on capital %7.721.2 36.2%  
Exports to sales %22.949.1 46.7%   
Imports to sales %14.37.4 192.0%   
Exports (fob) Rs m96467,244 1.4%   
Imports (cif) Rs m60210,199 5.9%   
Fx inflow Rs m96471,405 1.4%   
Fx outflow Rs m60717,807 3.4%   
Net fx Rs m35753,598 0.7%   
CASH FLOW
From Operations Rs m1,345-3,690 -36.4%  
From Investments Rs m-2,256-69,434 3.2%  
From Financial Activity Rs m-1,20058,126 -2.1%  
Net Cashflow Rs m-2,111-14,998 14.1%  

Share Holding

Indian Promoters % 4.5 46.6 9.7%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 0.0 11.3 -  
FIIs % 1.4 31.9 4.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 10.1 931.7%  
Shareholders   20,807 98,259 21.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   SANOFI INDIA  ABBOTT INDIA  STRIDES SHASUN LTD  WYETH LTD  ASTRAZENECA PHARMA  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Pharma Drug Approvals, Global Updates, Oil Prices, and Top Stocks in Action Today(Pre-Open)

Indian share markets snapped their losing streak seen during last week and closed their Wednesday session on a positive note.

Related Views on News

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Lupin: Key Products Drive US growth (Quarterly Results Update - Detailed)

Sep 12, 2016

Lupin has announced its 1QFY17results. Net sales have grown by 40% YoY and net profits have surged by 55.1% YoY. Here is our analysis of the results.

Securities & Intelligence Services Ltd. (IPO)

Jul 31, 2017

Should you subscribe to the IPO of Securities & Intelligence Services Ltd?

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS